PRZ-ATORVASTATIN

pharmaris canada inc🇨🇦 Health Canada

Approval Id: 6084673eda65e90c
Drug Approval Canada Name: PRZ-ATORVASTATIN
Product Name: PRZ-ATORVASTATIN
Status: Marketed
Status Date: 2022-09-19
Original Market Date: 2022-09-19
Din: 02521598
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:06.08
Atc Original: C10AA05 ATORVASTATIN
Atc Name: c 10 aa 05
Aig Number: 0133055004
Company Name: pharmaris canada inc
Company Address: 102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9

ATORVASTATIN (ATORVASTATIN CALCIUM)

80 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

6084673eda65e90c

Type

Standard